心脏毒性
重编程
阿霉素
医学
心功能曲线
药理学
不利影响
癌症研究
心脏纤维化
抗药性
药品
心力衰竭
下调和上调
化疗
癌症
癌细胞
心肌病
细胞毒性T细胞
心肌保护
纤维化
心肌细胞
心脏功能不全
胰岛素抵抗
流出
心肌纤维化
副作用(计算机科学)
作者
Yixin Zhang,Wenhua Li,Yingxian Xiao,Li Luo,Jiacong Ai,Shushan Mo,Lanya Li,Junyao Deng,Xueyi Wang,Qian Li,Yan Zeng,Huifang Liu,Fei Wang,Zhenhua Li
标识
DOI:10.1038/s41467-026-71843-9
摘要
Doxorubicin-induced cardiotoxicity represents a significant clinical adverse effect associated with cancer chemotherapy treatment. Inspired by cancer drug resistance mechanisms, we propose a novel strategy termed transient overexpression of p-glycoprotein for cardiac reprogramming to induce cardiac drug resistance as a treatment for cardiotoxicity. This approach involves reprogramming cardiomyocytes by delivering lipid nanoparticles-based mRNA therapeutics to induce temporary p-glycoprotein overexpression, which in turn reduces intracellular doxorubicin levels and suppresses cytotoxic effects. This strategy results in promoted p-glycoprotein overexpression in cardiomyocytes, improved survival rates, restored cardiac function, and reduced myocardial fibrosis and structural cardiac alterations in a mouse model with doxorubicin-induced cardiotoxicity. Furthermore, studies in large animals show that intrapericardial injection of lipid nanoparticles with p-glycoprotein mRNAs effectively mitigates adverse effects and restores cardiac function in male pig models of doxorubicin-induced cardiotoxicity. The significant cardioprotective effects achieved through cardiac drug resistance highlight the safety, efficacy, and clinical potential of this strategy for alleviating doxorubicin-induced cardiotoxicity. Doxorubicin-induced cardiotoxicity represents a critical adverse event in clinical cancer chemotherapy. Here, the authors show that cardiac administration of P-glycoprotein mRNA loaded lipid nanoparticles induces cardiac reprogramming and drug resistance, thereby effectively alleviating doxorubicin-induced cardiotoxicity in mice and pigs.
科研通智能强力驱动
Strongly Powered by AbleSci AI